Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01738984 · ClinicalTrials.gov registry record · Phase 3

A Home Exercise Program for Women With Infants & Young Children

A Phase 3 study, sponsored by University of Hawaii.

Completed
Registry status
Phase 3
Development phase
499
Enrollment target

NCT01738984: Completed Phase 3 study, sponsored by University of Hawaii.

NCT01738984 is a Phase 3 study that has completed, run by University of Hawaii. The registered enrollment target is 499 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01738984, a Phase 3 study, has completed, sponsored by University of Hawaii.

COMPLETED
Registry status
Phase 3
Development phase
499 participants
Enrollment target

Study Summary

This Phase II Small Business Technology Transfer(STTR) project will develop and test the effectiveness of an interactive web program optimized for use on a Internet connected television(TV), titled Moms Exercising or (MomZing) that is designed specifically for women with infants 2-8 months old. Moms will select from a menu of 98, 10-minute exercise videos demonstrating yoga, aerobics, and strengthening exercises. They select and sequence together exercise videos personalized to their fitness level, form of exercise, and the choice to actively exercise with her baby or alone. The primary health goal of the MomZing Program is to increase home-based Moderate to Vigorous Physical Activity (MPVA) minutes per week in new mothers and to maintain their exercise increases over time as their baby grows. The investigators hypothesize that women that use the MomZing Program will have greater increases in physical activity and fewer will return to cigarette smoking or alcohol use, compared to women who use a standard "mommy and me" exercise DVD.

Primary Outcome

physical activity will be obtained via online surveys at the 12 week assessment point

Interventions

  • BEHAVIORAL MomZing Web Program
  • BEHAVIORAL Standard Exercise DVD

Trial Details

FieldValue
Enrollment Target 499 participants
Start Date 2012-12
Est. Completion 2014-12
Phase Phase 3
University of Hawaii

77 total trials

What the finished NCT01738984 record still lists

NCT01738984 is an interventional study that assigns participants to a tested intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower).

The record links to 0 conditions, and to 2 interventions - of which MomZing Web Program is the first listed.

NCT01738984 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01738984 about?

NCT01738984 is a clinical study titled "A Home Exercise Program for Women With Infants & Young Children". This Phase II Small Business Technology Transfer(STTR) project will develop and test the effectiveness of an interactive web program optimized for use on a Internet connected television(TV), titled Moms Exercising or (MomZing) that is designed specifically for women with infants 2-8 months old. Moms...

What is the current status of trial NCT01738984?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 499 participants. The study started on 2012-12. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01738984?

The interventions under investigation include: MomZing Web Program (BEHAVIORAL), Standard Exercise DVD (BEHAVIORAL).

Who is sponsoring clinical trial NCT01738984?

This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01738984's enrollment target sits among peer trials

499 775th of 2000 higher than 1,226 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04137900 · 499 participants · Phase 1

    Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

  • NCT06733480 · 499 participants · NA

    Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01738984, the US trial registry maintained by the National Library of Medicine. NCT01738984 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.